Pre-order Enquiry
Request Free Sample
Global Nuclear Medicine & Radiopharmaceuticals Market Growth 2022-2028
SKU ID : LPI-19868670 | Publishing Date : 06-Jan-2022 | No. of pages : 91
Detailed TOC of Global Nuclear Medicine & Radiopharmaceuticals Market Growth 2022-2028
1 Scope of the Report1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceuticals by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceuticals by Country/Region, 2017, 2022 & 2028
2.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
2.2.1 Diagnostic
2.2.2 Therapeutic
2.3 Nuclear Medicine & Radiopharmaceuticals Sales by Type
2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue and Market Share by Type (2017-2022)
2.3.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Type (2017-2022)
2.4 Nuclear Medicine & Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Thyroid
2.4.3 Cardiology
2.4.4 Others
2.5 Nuclear Medicine & Radiopharmaceuticals Sales by Application
2.5.1 Global Nuclear Medicine & Radiopharmaceuticals Sale Market Share by Application (2017-2022)
2.5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Application (2017-2022)
3 Global Nuclear Medicine & Radiopharmaceuticals by Company
3.1 Global Nuclear Medicine & Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Company (2020-2022)
3.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2020-2022)
3.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Company (2020-2022)
3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2020-2022)
3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2020-2022)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Location Distribution
3.4.2 Players Nuclear Medicine & Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nuclear Medicine & Radiopharmaceuticals by Geographic Region
4.1 World Historic Nuclear Medicine & Radiopharmaceuticals Market Size by Geographic Region (2017-2022)
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Geographic Region
4.2 World Historic Nuclear Medicine & Radiopharmaceuticals Market Size by Country/Region (2017-2022)
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Country/Region
4.3 Americas Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.4 APAC Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.5 Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth
5 Americas
5.1 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country
5.1.1 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022)
5.1.2 Americas Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022)
5.2 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Type
5.3 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region
6.1.1 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region (2017-2022)
6.1.2 APAC Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2017-2022)
6.2 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Type
6.3 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nuclear Medicine & Radiopharmaceuticals by Country
7.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022)
7.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022)
7.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type
7.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022)
8.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type
8.3 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
10.4 Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine & Radiopharmaceuticals Distributors
11.3 Nuclear Medicine & Radiopharmaceuticals Customer
12 World Forecast Review for Nuclear Medicine & Radiopharmaceuticals by Geographic Region
12.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Region (2023-2028)
12.1.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Type
12.7 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Application
13 Key Players Analysis
13.1 China Isotope & Radiation
13.1.1 China Isotope & Radiation Company Information
13.1.2 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Offered
13.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 China Isotope & Radiation Main Business Overview
13.1.5 China Isotope & Radiation Latest Developments
13.2 Dongcheng
13.2.1 Dongcheng Company Information
13.2.2 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Offered
13.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Dongcheng Main Business Overview
13.2.5 Dongcheng Latest Developments
13.3 Jaco
13.3.1 Jaco Company Information
13.3.2 Jaco Nuclear Medicine & Radiopharmaceuticals Product Offered
13.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Jaco Main Business Overview
13.3.5 Jaco Latest Developments
13.4 Ciaeriar
13.4.1 Ciaeriar Company Information
13.4.2 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Offered
13.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ciaeriar Main Business Overview
13.4.5 Ciaeriar Latest Developments
13.5 Advanced Molecular-imaging Solution
13.5.1 Advanced Molecular-imaging Solution Company Information
13.5.2 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Offered
13.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Advanced Molecular-imaging Solution Main Business Overview
13.5.5 Advanced Molecular-imaging Solution Latest Developments
13.6 Shanghai Atom Kexing
13.6.1 Shanghai Atom Kexing Company Information
13.6.2 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Offered
13.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Shanghai Atom Kexing Main Business Overview
13.6.5 Shanghai Atom Kexing Latest Developments
14 Research Findings and Conclusion
List of Figures, Tables and Charts Available in Global Nuclear Medicine & Radiopharmaceuticals Market Growth 2022-2028
List of TablesTable 1. Nuclear Medicine & Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Nuclear Medicine & Radiopharmaceuticals Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Diagnostic
Table 4. Major Players of Therapeutic
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2017-2022) & ($ million)
Table 8. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
Table 9. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2017-2022)
Table 13. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2017-2022)
Table 14. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Nuclear Medicine & Radiopharmaceuticals Sales by Company (2020-2022) & (K Units)
Table 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2020-2022)
Table 17. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2020-2022)
Table 19. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 21. Players Nuclear Medicine & Radiopharmaceuticals Products Offered
Table 22. Nuclear Medicine & Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Geographic Region (2017-2022)
Table 27. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Nuclear Medicine & Radiopharmaceuticals Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country/Region (2017-2022)
Table 31. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 34. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 35. Americas Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 37. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 38. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 39. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 40. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 41. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 42. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Table 43. APAC Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2017-2022)
Table 45. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 46. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 47. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 48. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 49. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 50. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 51. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 53. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 54. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 55. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 56. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Nuclear Medicine & Radiopharmaceuticals
Table 66. Key Market Challenges & Risks of Nuclear Medicine & Radiopharmaceuticals
Table 67. Key Industry Trends of Nuclear Medicine & Radiopharmaceuticals
Table 68. Nuclear Medicine & Radiopharmaceuticals Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Nuclear Medicine & Radiopharmaceuticals Distributors List
Table 71. Nuclear Medicine & Radiopharmaceuticals Customer List
Table 72. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Forecast by Region
Table 74. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Application (2023-2028)
Table 92. China Isotope & Radiation Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 93. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 94. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. China Isotope & Radiation Main Business
Table 96. China Isotope & Radiation Latest Developments
Table 97. Dongcheng Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 98. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 99. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Dongcheng Main Business
Table 101. Dongcheng Latest Developments
Table 102. Jaco Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 103. Jaco Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 104. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Jaco Main Business
Table 106. Jaco Latest Developments
Table 107. Ciaeriar Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 108. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 109. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Ciaeriar Main Business
Table 111. Ciaeriar Latest Developments
Table 112. Advanced Molecular-imaging Solution Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 113. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 114. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Advanced Molecular-imaging Solution Main Business
Table 116. Advanced Molecular-imaging Solution Latest Developments
Table 117. Shanghai Atom Kexing Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 118. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 119. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Shanghai Atom Kexing Main Business
Table 121. Shanghai Atom Kexing Latest Developments
List of Figures
Figure 1. Picture of Nuclear Medicine & Radiopharmaceuticals
Figure 2. Nuclear Medicine & Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Nuclear Medicine & Radiopharmaceuticals Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Diagnostic
Figure 10. Product Picture of Therapeutic
Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2021
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
Figure 13. Nuclear Medicine & Radiopharmaceuticals Consumed in Oncology
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Market: Oncology (2017-2022) & (K Units)
Figure 15. Nuclear Medicine & Radiopharmaceuticals Consumed in Thyroid
Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Market: Thyroid (2017-2022) & (K Units)
Figure 17. Nuclear Medicine & Radiopharmaceuticals Consumed in Cardiology
Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Market: Cardiology (2017-2022) & (K Units)
Figure 19. Nuclear Medicine & Radiopharmaceuticals Consumed in Others
Figure 20. Global Nuclear Medicine & Radiopharmaceuticals Market: Others (2017-2022) & (K Units)
Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application in 2021
Figure 23. Nuclear Medicine & Radiopharmaceuticals Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company in 2021
Figure 25. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Geographic Region in 2021
Figure 27. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country/Region in 2021
Figure 29. Americas Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 30. Americas Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 31. APAC Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 32. APAC Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 33. Europe Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 34. Europe Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 37. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 38. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 39. United States Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2021
Figure 44. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions in 2021
Figure 45. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 52. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 53. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 60. Egypt Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals in 2021
Figure 66. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
Figure 67. Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Request Sample
Request Discount
